Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease

Published:2018-01-24 Issue:13 Volume:61 Page:5467-5483
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wu Yinuo¹,Li Zhe¹,Huang Yi-You¹,Wu Deyan¹,Luo Hai-Bin¹^ORCID

Affiliation:

1. School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Foundation of Traditional Chinese Medicine Bureau of Guangdong Province

Guangdong Province

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b01370

Reference160 articles.

1. The prion model for progression and diversity of neurodegenerative diseases

2. Alzheimer’s Disease International. World Alzheimer Report 2015. ps://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf.

3. A Century of Alzheimer's Disease

4. Alzheimer Mechanisms and Therapeutic Strategies

5. Leading Alzheimer’s theory survives drug failure

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease;European Journal of Medicinal Chemistry;2024-12

2. Structural optimization and bioactivity evaluation of 2-(Methylcarbonylamino) thiazole derivatives as novel PDE4B inhibitors;Tetrahedron;2024-11

3. PDE4D: A Multipurpose Pharmacological Target;International Journal of Molecular Sciences;2024-07-24

4. The therapeutic potential of phosphodiesterase 9 (PDE9) inhibitors: a patent review (2018-present);Expert Opinion on Therapeutic Patents;2024-07-09

5. Corydalis ternata Nakai Alleviates Cognitive Decline in Alzheimer's Disease by Reducing β-Amyloid and Neuroinflammation;Rejuvenation Research;2024-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3